4//SEC Filing
Maynard Ryan D 4
Accession 0001209191-22-049931
CIK 0001346830other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:42 PM ET
Size
5.6 KB
Accession
0001209191-22-049931
Insider Transaction Report
Form 4
Maynard Ryan D
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-12+225,000→ 225,000 totalExercise: $10.75Exp: 2032-09-12→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]25% of the shares will vest and become exercisable on September 12, 2023 and the remainder will vest over the following 36 equal monthly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001363984
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:42 PM ET
- Size
- 5.6 KB